Why Are Millions of U.S. Veterans Turning to Psychedelics?
TL;DR
•A recent RAND study estimates that 4.8 million U.S. veterans have used psychedelics like psilocybin, LSD, or MDMA in their lifetime.
•Veterans are increasingly turning to these substances as potential treatments for severe PTSD, depression, and other service-related mental health conditions.
•Despite growing interest and new clinical trials funded by the VA, many veterans are hesitant to discuss their psychedelic use with VA doctors for fear of losing their benefits.
•MDMA-assisted therapy is currently showing strong clinical promise for treating PTSD, leading to accelerated research efforts and trials specifically for veterans.
For many U.S. veterans, returning home from service is just the beginning of a new battle. Conditions like post-traumatic stress disorder (PTSD), severe depression, and anxiety are alarmingly common, and traditional treatments do not always provide the relief they need. Driven by a desire to heal, a growing number of veterans are exploring alternative options. In fact, a recent study by the RAND Corporation estimates that nearly 5 million U.S. veterans have used psychedelic substances like psilocybin mushrooms, LSD, or MDMA in their lifetime.
Why are so many veterans turning to these once-taboo substances? The answer lies in the profound therapeutic potential that psychedelics are showing in clinical research, particularly for trauma. In this article, we will explore why veterans are seeking out psychedelics, what the latest clinical trials are uncovering, and the complex relationship between veterans and the Department of Veterans Affairs (VA) regarding these treatments.
The Search for Better PTSD Treatments
PTSD is notoriously difficult to treat. While evidence-based therapies like Cognitive Processing Therapy (CPT) and Prolonged Exposure (PE) work well for some, many veterans drop out of treatment or find that their symptoms persist. This gap in care has led researchers and veterans alike to look for new solutions.
Enter MDMA-assisted therapy. MDMA, often referred to as a non-classic psychedelic, has unique properties that make it particularly suited for trauma therapy. According to the VA's National Center for PTSD, MDMA increases feelings of safety, social engagement, and empathy, while simultaneously reducing the fear response in the brain's amygdala (1). This combination allows patients to recall and process traumatic memories without becoming overwhelmed by panic or emotional numbing.
In recent Phase 3 clinical trials, MDMA-assisted therapy demonstrated large, statistically significant reductions in PTSD symptom severity compared to a placebo (1). For veterans who have spent years feeling stuck in "fight or flight" mode, the ability to safely process their trauma represents a massive breakthrough.
A Growing Acceptance Among Veterans
The RAND study highlights a significant shift in how veterans view psychedelics (2). Not only have 4.8 million veterans used these substances, but nearly one in four (23%) support the legal use of psilocybin mushrooms, and 11% support the legal use of LSD—rates that are higher than the general population.
This growing acceptance is largely driven by grassroots veteran organizations that advocate for psychedelic access. Many veterans who have experienced profound healing through psychedelics—often traveling outside the U.S. to do so—have become vocal proponents, sharing their stories of overcoming treatment-resistant depression and suicidal ideation.
If you are curious about how these therapies are actually administered in a clinical setting, you can learn more in our post, What is Psychedelic-Assisted Therapy?.
The VA's Evolving Stance
The federal government is beginning to catch up to the veteran community's interest. In 2026, following an executive order to accelerate medical treatments for serious mental illness, the VA launched a new randomized controlled trial to evaluate MDMA-assisted therapy for PTSD and alcohol use disorder in veterans (3). This trial, alongside millions of dollars in Defense Department grants for psychedelic research, signals a major shift in institutional attitudes.
However, despite these top-down initiatives, there is still significant confusion and fear among veterans on the ground. The RAND study found that about half of veterans were unsure if discussing their use of psychedelics with their VA doctor would jeopardize their VA benefits (2).
While the VA has clear policies protecting veterans who discuss marijuana use, no such specific protections currently exist for psychedelics. The VA officially discourages self-medicating with unprescribed substances, urging veterans to rely on proven treatments (3). This creates a difficult situation for veterans who are finding relief through naturalistic or underground psychedelic use but feel they must hide it from their primary healthcare providers.
Conclusion
The fact that nearly 5 million U.S. veterans have explored psychedelics is a clear indicator that current mental health treatments are not meeting everyone's needs. As clinical trials continue to show the profound benefits of MDMA and psilocybin for PTSD, the conversation is rapidly shifting from stigma to science.
For veterans, the hope is that these treatments will soon become legally accessible, safely administered, and fully integrated into VA care without the fear of losing benefits. Until then, the veteran community continues to lead the charge, advocating for the right to heal.
If you are a veteran or someone who loves a veteran, reading about these new therapies might bring up a lot of questions. It is completely normal to feel hopeful but also cautious about treatments that are still navigating legal and clinical hurdles.
If you are currently exploring your options for trauma recovery and are looking for a safe, non-judgmental space to process your experiences—whether that involves traditional therapy or integrating a past psychedelic experience—I am here to help. Schedule a free consultation with Jeff Jones, LPC
About the Author:
This article was written by Jeff Jones, a Licensed Professional Counselor (LPC) in Texas in practice since 1999. He is a 2024 graduate of the CIIS Center for Psychedelic Therapies and Research program. With a compassionate and evidence-based approach, he helps clients navigate life's challenges and find a path toward healing.
Disclaimer:
The information in this article, including discussions of psychedelic-assisted psychotherapy, is for informational purposes only. Psychedelic-assisted psychotherapy has not been approved by all regulatory agencies in the United States, and its safety and efficacy are still being established. This content is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
1.Psychedelic-Assisted Therapy for PTSD
2.Nearly 5 million veterans have used magic mushrooms, LSD or MDMA, study finds